Decrease Errors With Newer Insulins
July 2026
Errors with newer insulins are bringing insulin safety to the forefront again.
More patients are switching products as new insulins become available. For instance, patients may switch to a more affordable biosimilar or a more convenient longer-acting formulation.
But this also brings up new opportunities for errors.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive